Julien Peron, O. Tredan, I. Ray-Coquard, T. Bachelot, S. I. Labidi Galy, et al.. First-line endocrine therapy alone could be a reasonable treatment option for hormone-positive, HER2-positive metastatic breast cancer.
Bulletin du cancer, 2012, 99, pp.E18-25.
⟨10.1684/bdc.2011.1537⟩.
⟨hal-02282750⟩ 
